GlycoMimetics, Inc. ( GLYC) - Stock Earnings
Stock symbol GLYC is outdated, potentially delisted? Maybe it is available on other exchange?
GLYC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -9.8 million USD | — USD |
| 2023Q2 | -8.3 million USD | — USD |
| 2023Q3 | -9.2 million USD | — USD |
GLYC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -63.1 million USD | 1.2 million USD |
| 2022 | -93.3 million USD | 74925 USD |
| 2023 | -38.1 million USD | — USD |
GLYC
Price: $15.70
52 week price:
Earnings Per Share: -46.00 USD
P/E Ratio: -0.34
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.7 million
Ebitda: -8.1 millionMarket Capitalization: 1.0 billion